 07 PM / Updated 9 minutes ago BRIEF-Merus Provides Clinical Updates For Mcla-117 And Mcla-158 Programs Reuters Staff 
Jan 4 (Reuters) - Merus Nv: 
* MERUS PROVIDES CLINICAL UPDATES FOR MCLA-117 AND MCLA-158 PROGRAMS 
* MERUS NV - PLANS TO FILE AN IND FOR MCLA-158 WITH U.S. FDA IN Q1 OF 2018​ 
* MERUS NV - APPROVAL OF CLINICAL TRIAL APPLICATION IN BELGIUM, WHERE IT PLANS TO FIRST INITIATE PHASE 1, FIRST-IN-HUMAN CLINICAL TRIAL OF MCLA-158​ Source text for Eikon:  